Editorially Independent Content, Supported with Advertising from Allergan XEN, Glaukos iDose & Nova Eye.
John P. Berdahl, MD; Natalia Morales, MD; and Justin Schweitzer, OD, FAAO
Show Description +
John P. Berdahl, MD; Natalia Morales, MD; and Justin Schweitzer, OD, FAAO, review the case of a 78-year-old patient who previously underwent cataract surgery and stent implantation for severe glaucoma in his left eye. The patient returned to the office with a cataract and ocular hypertension in his right eye. He was already prescribed a topical prostaglandin analogue, had an IOP of 28 mm Hg OD, and showed no evidence of optic nerve damage. The panelists weigh insurance coverage, quality-of-life improvements, and other factors to consider when choosing an option for lowering IOP alongside cataract surgery.
Posted: 11/09/2026
John P. Berdahl, MD; Natalia Morales, MD; and Justin Schweitzer, OD, FAAO
John P. Berdahl, MD; Natalia Morales, MD; and Justin Schweitzer, OD, FAAO, review the case of a 78-year-old patient who previously underwent cataract surgery and stent implantation for severe glaucoma in his left eye. The patient returned to the office with a cataract and ocular hypertension in his right eye. He was already prescribed a topical prostaglandin analogue, had an IOP of 28 mm Hg OD, and showed no evidence of optic nerve damage. The panelists weigh insurance coverage, quality-of-life improvements, and other factors to consider when choosing an option for lowering IOP alongside cataract surgery.
Posted: 11/09/2026
Please log in to leave a comment.